Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis.

Tseng, Po-Lin

Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis. [electronic resource] - Journal of viral hepatitis Jul 2005 - 386-92 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1352-0504

10.1111/j.1365-2893.2005.00608.x doi


Adenine--analogs & derivatives
Adult
Aged
Antiviral Agents--therapeutic use
Drug Resistance, Viral--genetics
Female
Hepatic Encephalopathy
Hepatitis B virus--drug effects
Hepatitis B, Chronic--complications
Humans
Lamivudine--therapeutic use
Liver Cirrhosis--drug therapy
Male
Middle Aged
Mutation
Organophosphonates--therapeutic use
Survival Analysis
Taiwan